Stay updated on Isatuximab for High-Risk Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.

Latest updates to the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed in the history. This looks like a system update with no changes to the study information visible on the page.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check52 days agoChange DetectedFooter revision updated from v3.4.1 to v3.4.2; no substantive changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed from the history display.SummaryDifference0.1%

- Check82 days agoChange DetectedA new Revision: v3.3.4 was added to the history, and Revision: v3.3.3 was removed.SummaryDifference0.1%

- Check103 days agoChange DetectedThe page history shows a new Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure footer link, which are administrative site updates and do not affect trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Isatuximab for High-Risk Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.